(Reuters) -The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. Read...
Vous n'êtes pas connecté
The FDA has approved updated Covid-19 vaccines from Pfizer and Moderna targeting the KP.2 variant for an autumn vaccination drive. These vaccines are expected to provide better protection against severe symptoms of circulating variants. The shots for children below 12 years are cleared under the agency's emergency use authorization pathway. Novavax's protein-based vaccine is still under review.
(Reuters) -The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. Read...
The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans: Get the shot now, with...
The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country.
Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly...
FDA Clears Pfizer and Moderna 2024-2025 COVID-19 mRNA Vaccines On August 22, the FDA approved the latest COVID-19 mRNA monovalent vaccines from...
Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according...
Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according...
GAITHERSBURG, Md., Aug. 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™...
Opposition Leader Kamla Persad-Bissessar has criticised the government for its handling of the healthcare system, particularly during covid19. She...
The ZetaTalk Newsletter MonkeyPoxMonkey Pox or MPox as it is also called has been endemic in Africa for eons, and occasionally escapes Africa to be...